sb.scorecardresearch
Advertisement

Published 23:08 IST, October 22nd 2020

Covaxin, Bharat Biotech's COVID vaccine, gets DCGI approval for phase 3 of clinical trials

India's indigenous developed COVID-19 vaccine - Covaxin - has been cleared by the Drug Controller General of India (DGCI) for the third phase of clinical trials

Reported by: Jitesh Vachhatani
Follow: Google News Icon
  • share
Coronavirus
null | Image: self
Advertisement

Loading...

21:52 IST, October 22nd 2020